ArticleJournal, genetic engineering & biotechnology2025
Targeting cholinergic dysfunction in Alzheimer's disease: Development of next-generation galantamine derivatives.
Zahra Keshavarz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.